SpringWorks Therapeutics Inc

SWTX

Market Cap$3.52B

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
SpringWorks Therapeutics Inc	-13.8	-	-61%	23.4	0.1

$47.00

Target Price by Analysts

0.4% upsideSpringWorks Therapeutics Target Price Details

$-36.10

Current Fair Value

177.1% downside

Overvalued by 177.1% based on the discounted cash flow analysis.

Share Statistics

Market cap	$3.52 Billion
Enterprise Value	$3.48 Billion
Dividend Yield	$0 (0%)
Earnings per Share	$-3.48
Beta	0.77
Outstanding Shares	74,885,348

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-13.77
PEG	286.74
Price to Sales	23.4
Price to Book Ratio	9.36
Enterprise Value to Revenue	15.83
Enterprise Value to EBIT	-13.14
Enterprise Value to Net Income	-14
Total Debt to Enterprise	0.01
Debt to Equity	0.05

Revenue Sources

No data

Insider Trades

ESG Score

No data

About SpringWorks Therapeutics Inc